Next Article in Journal
Development and Validation of a Liquid Chromatography-Mass Spectrometry Method for the Determination of Zileuton in Human Plasma
Previous Article in Journal
Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle

HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats

1
Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, MehsanaGojaria Highway, Gujarat, 382014, India
2
Babria Institute of Pharmacy, Vadodara, 391240, Gujarat, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2014, 82(3), 555-570; https://doi.org/10.3797/scipharm.1401-18
Received: 23 January 2014 / Accepted: 13 March 2014 / Published: 13 March 2014
Carotid intima-media thickness is used as a surrogate marker for cardiovascular complications in diabetes mellitus. The combination of atorvastatin and pioglitazone was found to be effective in reducing the thickness of the carotid intima-media layer. The method of RP-HPLC coupled with a diode array detector (DAD) was developed for the pharmacokinetic interaction study of atorvastatin with pioglitazone and cholestyramine, respectively, in Wistar rats. Atorvastatin (ATR) and pioglitazone (PIO) were resolved on a C18 column with a mobile phase composed of 48% methanol, 19% acetonitrile, and 33% 10 mM ammonium formate (v/v/v; pH 3.5±0.3, by formic acid) and a 260 nm detection wavelength on the diode array detector. The method was validated according to international standards with good reproducibility and linear response; mean (r) 0.9987 and 0.9972 to ATR and PIO, respectively. The coefficients of variation of intra- and interassay precision ranged between 4.95–8.12 and 7.29–9.67, respectively. Pharmacokinetic parameters were determined in rats following an oral administration of atorvastatin in the presence and absence of pioglitazone and also with cholestyramine. Compared with the control given atorvastatin alone, the Cmax and AUC of atorvastatin were merely unchanged in rats with the co-administration of pioglitazone, while they decreased by nearly 21 and 15%, respectively, with the concurrent use of cholestyramine. There were no significant changes in Tmax and the plasma half-life (T1/2) of atorvastatin in both cases. The performed experiment demonstrated that the presented method was suitable for the estimation and pharmacokinetic interaction study of atorvastatin with pioglitazone and cholestyramine in Wistar rat plasma.
Keywords: Atorvastatin; Pioglitazone; Cholestyramine; Pharmacokinetic; Liquid-liquid Extraction; RP-HPLC-DAD Atorvastatin; Pioglitazone; Cholestyramine; Pharmacokinetic; Liquid-liquid Extraction; RP-HPLC-DAD
MDPI and ACS Style

SHARMA, R.N.; PANCHOLI, S.S. HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats. Sci. Pharm. 2014, 82, 555-570. https://doi.org/10.3797/scipharm.1401-18

AMA Style

SHARMA RN, PANCHOLI SS. HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats. Scientia Pharmaceutica. 2014; 82(3):555-570. https://doi.org/10.3797/scipharm.1401-18

Chicago/Turabian Style

SHARMA, Ritesh N.; PANCHOLI, Shyam S. 2014. "HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats" Sci. Pharm. 82, no. 3: 555-570. https://doi.org/10.3797/scipharm.1401-18

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop